Precigen Inc R&D Update Virtual Event Transcript
Good day and welcome to the Precigen R&D Update and Clinical Development Call. (Operator Instructions) Please note that this event is being recorded. I would now like to turn the conference over to Steven Harasym, Head of Investor Relations. Please go ahead, sir.
Thank you, Chuck. This is a very exciting time at Precigen, and I would like to extend a special thanks to everyone joining us today for an update on our clinical programs.
Next slide, please. Before we begin, I would like to remind you that, during today's call, we will make various forward-looking statements. Investors are cautioned that our forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those indicated by our looking statements. Please read the safe harbor statement contained in this presentation as well as the risk factors contained in Precigen's most recent SEC filings for a more complete discussion of these risks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |